The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer

被引:15
作者
Jatoi, Aminah [1 ]
Qi, Yingwei [2 ]
Kendall, Glenda
Jiang, Ruoxiang
McNallan, Sheila
Cunningham, Julie [3 ]
Mandrekar, Sumithra [2 ]
Yang, Ping [4 ]
机构
[1] Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
Cancer-associated anorexia; Single nucleotide polymorphism; Non-small cell lung cancer; WEIGHT-LOSS; SURVIVAL; CACHEXIA;
D O I
10.1007/s00520-009-0748-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cancer anorexia/weight loss syndrome commonly occurs in patients with non-small cell lung cancer (NSCLC) and is characterized by loss of weight and appetite as well as diminished survival. The current study explored whether any of 22 single nucleotide polymorphisms (SNPs) of certain previously implicated inflammatory cytokines (interleukin-1 beta, interleukin-1RN, interleukin-6, and tumor necrosis factor) are associated with this syndrome. All NSCLC patients who had been enrolled in the Mayo Clinic Lung Cancer Cohort, had completed a health-related questionnaire approximately 6 months after enrollment, and had blood drawn were included in this study, thus yielding a sample size of 471 patients. Sixty-six (14%) patients manifested weight loss shortly after diagnosis, and 152 (32%) reported appetite loss. Only tumor necrosis factor alpha rs800629 was associated with anorexia (odds ratio: 0.46; 95% confidence interval: 0.29, 0.72; p < 0.001); patients who were heterozygous and minor homozygous were less likely to suffer anorexia. Otherwise, there were no statistically significant associations between any of the other 21 SNPs and weight loss and/or anorexia. In univariate analyses, weight loss, anorexia, more advanced cancer stage, and interleukin-1 beta rs1143627 were associated with a worse survival, and interleukin-6 rs2069835 was associated with better survival. However, in multivariate analyses, cancer stage and patient age were the only statistically significant predictors of worse survival. No specific SNP was associated with all aspects of the cancer anorexia/weight loss syndrome, but rs800629 may merit further study in cancer-associated anorexia.
引用
收藏
页码:1299 / 1304
页数:6
相关论文
共 15 条
[1]   Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: A randomized, clinical trial [J].
Bozzetti, F ;
Gavazzi, C ;
Miceli, R ;
Rossi, N ;
Mariani, L ;
Cozzaglio, L ;
Bonfanti, G ;
Piacenza, S .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2000, 24 (01) :7-14
[2]   Prediction of survival in terminal cancer patients in Taiwan: Constructing a prognostic scale [J].
Chuang, RB ;
Hu, WY ;
Chiu, TY ;
Chen, CY .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (02) :115-122
[3]   PROGNOSTIC EFFECT OF WEIGHT-LOSS PRIOR TO CHEMOTHERAPY IN CANCER-PATIENTS [J].
DEWYS, WD ;
BEGG, C ;
LAVIN, PT ;
BAND, PR ;
BENNETT, JM ;
BERTINO, JR ;
COHEN, MH ;
DOUGLASS, HO ;
ENGSTROM, PF ;
EZDINLI, EZ ;
HORTON, J ;
JOHNSON, GJ ;
MOERTEL, CG ;
OKEN, MM ;
PERLIA, C ;
ROSENBAUM, C ;
SILVERSTEIN, MN ;
SKEEL, RT .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :491-497
[4]   Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors [J].
Dhiman, Neelam ;
Poland, Gregory A. ;
Cunningham, Julie M. ;
Jacobson, Robert M. ;
Ovsyannikova, Inna G. ;
Vierkant, Robert A. ;
Wu, Yanhong ;
Pankratz, V. Shane .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) :666-672
[5]   Serum levels of tumour necrosis factor-α and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate -: preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy [J].
Grim-Stieger, M. ;
Keilani, M. ;
Mader, R. M. ;
Marosi, C. ;
Schmidinger, M. ;
Zielinski, C. ;
Fialka-Moser, V. ;
Crevenna, R. .
EUROPEAN JOURNAL OF CANCER CARE, 2008, 17 (05) :454-462
[6]   Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone [J].
Jeremic, Branislav ;
Milicic, Biljana ;
Dagovic, Aleksandar ;
Acimovic, Ljubisa ;
Milisavljevic, Slobodan .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04) :1112-1119
[7]   PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETED QUESTIONNAIRES [J].
LOPRINZI, CL ;
LAURIE, JA ;
WIEAND, HS ;
KROOK, JE ;
NOVOTNY, PJ ;
KUGLER, JW ;
BARTEL, J ;
LAW, M ;
BATEMAN, M ;
KLATT, NE ;
DOSE, AM ;
ETZELL, PS ;
NELIMARK, RA ;
MAILLIARD, JA ;
MOERTEL, CG .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :601-607
[8]   CONTROLLED TRIAL OF MEGESTROL-ACETATE FOR THE TREATMENT OF CANCER ANOREXIA AND CACHEXIA [J].
LOPRINZI, CL ;
ELLISON, NM ;
SCHAID, DJ ;
KROOK, JE ;
ATHMANN, LM ;
DOSE, AM ;
MAILLIARD, JA ;
JOHNSON, PS ;
EBBERT, LP ;
GEERAERTS, LH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1127-1132
[9]  
Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4
[10]  
ROLEDO R, 2003, GENOMICS, V82, P580